Preimplantation Genetic Testing for Aneuploidies (PGT-A)

March 23, 2025
Preimplantation Genetic Testing for Aneuploidies (PGT-A)

Preimplantation Genetic Testing for Aneuploidies (PGT-A) is a groundbreaking advancement in reproductive technology. It plays a crucial role in identifying chromosomal anomalies that could impact pregnancy outcomes, making it a valuable tool in fertility treatments. Here’s a closer look at what PGT-A involves and why it matters.


Understanding Aneuploidies

Aneuploidies occur when there is an abnormal number of chromosomes in a cell, differing from the typical 23 pairs found in healthy human embryos. These chromosomal irregularities can lead to:

  • Genetic disorders like Down Syndrome or Edwards’ Syndrome.
  • Miscarriages due to non-viable embryos.

The PGT-A Process

PGT-A involves screening embryos for chromosomal abnormalities during an IVF cycle.

Key Steps:

  1. Embryo Development: The process begins on day 5 or 6 of embryo growth.
  2. Cell Biopsy: A few cells are carefully extracted from each embryo.
  3. Genetic Analysis: The extracted cells undergo detailed genetic testing to detect aneuploidies.

This procedure ensures that only chromosomally normal embryos are selected for transfer, significantly improving the chances of a successful pregnancy and reducing the risk of genetic disorders.


Who Should Consider PGT-A?

PGT-A is particularly beneficial for:

  • Women over 35: The risk of chromosomal abnormalities increases with age.
  • Couples with a history of recurrent miscarriages or failed IVF cycles, potentially caused by chromosomal issues.
  • Individuals or couples with a known risk of passing on genetic chromosomal disorders.

Is PGT-A Safe?

Yes, PGT-A is a safe and routine procedure performed by experienced embryologists. It is an integral part of modern IVF treatments, known for its high reliability and precision in detecting chromosomal abnormalities.


Benefits of PGT-A

1. Enhanced Pregnancy Success

PGT-A improves IVF success rates by ensuring only chromosomally normal embryos are selected for transfer.

2. Reduced Risk of Genetic Disorders

The procedure minimizes the likelihood of passing on genetic conditions, offering peace of mind to hopeful parents.

3. Tailored Fertility Solutions

PGT-A helps identify viable embryos, reducing the emotional and financial strain of repeated IVF cycles.


Additional Considerations

While PGT-A offers significant benefits, it’s essential to undergo thorough pre-treatment screenings to determine if this procedure is suitable for your specific situation. Consulting a fertility specialist at Sakalli IVF will provide personalized guidance.


Conclusion

PGT-A is a transformative tool for improving IVF success rates and reducing the risk of genetic conditions. If you’re considering fertility treatments, Sakalli IVF is here to guide you with expert care and compassionate support.

Contact us today to learn more about PGT-A or to schedule a personalized consultation.

Copyright © Sakalli IVF. All rights reserved